In this section

ICR publications

ICR ImmNet publications feed

Browse all ICR publications

The frequency and prognostic relevance of co-occurring TP53 mutation and NOTCH pathway activation in locally advanced, recurrent or metastatic adenoid cystic carcinoma.

01 July 2026
Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.

15 June 2026
Phase 1 study of ceralasertib, an ATR kinase inhibitor, in combination with durvalumab in patients with recurrent or metastatic NSCLC or HNSCC.

05 June 2026
The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes.

01 June 2026
Somatic evolution following cancer treatment in normal tissue.

21 May 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

15 May 2026
Expanding the human proteome with microproteins and peptideins.

06 May 2026
Efficacy and safety of stereotactic radiosurgery in the management of brain metastases in patients with metastatic melanoma.

01 May 2026
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

01 May 2026
A Cost-Analysis and Micro-Costing Study of the Man Van Project: Comparing Prostate-Specific Antigen Testing Via a Nurse-Led Mobile Service with Primary Care.

01 May 2026
Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

29 April 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion.

27 April 2026